Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine

Veterinary Research

Volumn 41, Issue 3, 2010, Pages

  Ong, Wei C ^a   Jin, Hong ^a   Jiang, Chengda ^a   Yan, Weiyao ^a   Liu, Mingqiu ^a   Chen, Jiulian ^b   Zuo, Xiaoping ^b   Zheng, Zhaoxin ^a  

^a FUDAN UNIVERSITY   (China)

^b Bio pharmacy   (China)

Author keywords

Conserved sequence; Foot and mouth disease virus; RNA interference; Salmonella choleraesuis; Swine

Indexed keywords

BACTERIAL VACCINE; LIVE VACCINE; SMALL INTERFERING RNA; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; CHEMISTRY; CLASSIFICATION; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; GENETICS; GUINEA PIG; HAMSTER; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PLASMID; RNA INTERFERENCE; SALMONELLA; SUCKLING; SWINE; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANIMALS, SUCKLING; BACTERIAL VACCINES; CELL LINE; CONSERVED SEQUENCE; CRICETINAE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION, VIRAL; GUINEA PIGS; HUMANS; MICE; MICE, INBRED C57BL; PLASMIDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALMONELLA; SWINE; VACCINES, ATTENUATED; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 84864806603     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres/2010002     Document Type: Article

References (49)

1. Bachrach H. L., Foot-and-mouth disease virus, Annu. Rev. Microbiol. (1968) 22:201-244.
2. Barnett P. V., Carabin H., A review of emergency foot-and-mouth disease (FMD) vaccines, Vaccine (2002) 20:1505-1514. (Pubitemid 34169790)
3. Bitko V., Musiyenko A., Shulyayeva O., Barik S., Inhibition of respiratory viruses by nasally administered siRNA, Nat. Med. (2005) 11:50-55. (Pubitemid 40215837)
4. Brown C. C., Piccone M. E., Mason P. W., McKenna T. S.-C., Grubman M. J., Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle, J. Virol. (1996) 70:5638-5641. (Pubitemid 26240742)
5. Chen W., Yan W., Du Q., Fei L., Liu M., Ni Z., et al., RNA interference targeting VP1 inhibits footand-mouth disease virus replication in BHK-21 cells and suckling mice, J. Virol. (2004) 78:6900-6907. (Pubitemid 38781528)
6. Chen W., Liu M., Jiao Y., Yan W., Wei X., Chen J., et al., Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo, J. Virol. (2006) 80:3559-3566.
7. Chenard G., Miedema K., Moonen P., Schrijver R. S., Dekker A., A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology, J. Virol. Methods (2003) 107:89-98. (Pubitemid 35373911)
8. Curtiss R. T., Hassan J. O., Herr J., Kelly S. M., Levine M., Mahairas G. G., et al., Nonrecombinant and recombinant avirulent Salmonella vaccine, in: Talwar G. P., Rao K. V. S., Chauhan V. S. (Eds.), Recombinant and synthetic vaccines, Norosa Publishing House, New Delhi, India, 1994, pp. 340-351.
9. Darji A., Guzman C. A., Gerstel B., Wachholz P., Timmis K. N., Wehland J., et al., Oral somatic transgene vaccination using attenuated S. typhimurium, Cell (1997) 91:765-775. (Pubitemid 28007733)
10. Darji A., Lage S. Z., Garbe A. I., Chakraborty T., Weiss S., Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier, FEMS Immunol. Med. Microbiol. (2000) 27:341-349. (Pubitemid 30155829)
11. De los Santos T., Wu Q., de Avila Botton S., Grubman M. J., Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus, Virology (2005) 335:222-231. (Pubitemid 40544911)
12. Dietrich G., Gentschev I., Hess J., Ulmer J. B., Kaufmann S. H. E., Goebel W., Delivery of DNA vaccines by attenuated intracellular bacteria, Trends Immunol. Today (1999) 20:251-253. (Pubitemid 29258160)
13. Fang X. W., Li Y. L., Huang C. B., Zheng M., Feng W. D., Sun W., Live vaccine against swine paratyphoid from the attenuated smooth strain C500 of Salmonella choleraesuis, Acta Veterinaria Zootechnica Sinica (1981) 12:99-106.
14. Fountaine T. M., Wood M. J. A., Wade-Martins R., Delivering RNA interference to the mammalian brain, Curr. Gene Ther. (2005) 5:399-410. (Pubitemid 41052431)
15. Geisbert T. W., Hensley L. E., Kagan E., Yu E. Z., Geisbert J. B., Daddario-DiCaprio K., et al., Post exposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference, J. Infect. Dis. (2006) 193:1650-1657. (Pubitemid 43839469)
16. Gitlin L., Karelsky S., Andino R., Short interfering RNA confers intracellular antiviral immunity in human cells, Nature (2002) 418:430-434. (Pubitemid 34826844)
17. Gitlin L., Andino R., Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing, J. Virol. (2003) 77:7159-7165. (Pubitemid 36734484)
18. Gray J., Fedorka-Cray P., Stabel T., Ackermann M., Influence of inoculation route on the carrier state of Salmonella choleraesuis in swine, Vet. Microbiol. (1995) 47:43-59.
19. Grubman M. J., Baxt B., Foot-and-mouth disease, Clin. Microbiol. Rev. (2004) 17:465-493. (Pubitemid 38534037)
20. Grubman M. J., de los Santos T., Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution? Trends Immunol. (2005) 26:65-68.
21. Hohjoh H., RNA interference (RNA (i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells, FEBS Lett. (2002) 521:195-199. (Pubitemid 34628484)
22. Hohjoh H., Enhancement of RNAi activity by improved siRNA duplexes, FEBS Lett. (2004) 557:193-198. (Pubitemid 38115894)
23. Holen T., Amarzguioui M., Wiiger M. T., Babaie E., Prydz H., Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor, Nucleic Acids Res. (2002) 30:1757-1766. (Pubitemid 34679753)
24. Kahana R., Kuznetzova L., Rogel A., Shemesh M., Hai D., Yadin H., Stram Y., Inhibition of foot-andmouth disease virus replication by small interfering RNA, J. Gen. Virol. (2004) 85:3213-3217. (Pubitemid 39445438)
25. Kim S., Lee K., Park J., Ko Y., Joo Y., Kim H., Park J., Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo, Antiviral. Res. (2008) 80:178-184.
26. King A. M., Underwood B. O., McCahon D., Newman J. W., Brown F., Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK, Nature (1981) 293:479-480. (Pubitemid 12193179)
27. Li B. J., Tang Q., Cheng D., Qin C., Xie F. Y., Wei Q., et al., Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque, Nat. Med. (2005) 11:944-951. (Pubitemid 41294439)
28. Liu M., Chen W., Ni Z., Yan W., Fei L., Jiao Y., et al., Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome, Virology (2005) 336:51-59. (Pubitemid 40603670)
29. Liu M., Niu X., Yan J., Yan W., Zheng Z., Immure response induced by oral DNA vaccination against FMDV delivered by attenuated Salmonella choleraesuis C500, Front. Biol. China (2006) 2:110-114. (Pubitemid 44072566)
30. Lu S., Cullen B. R., Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and microRNA biogenesis, J. Virol. (2004) 78:12868-12876. (Pubitemid 39507795)
31. Mason P. W., Piccone M. E., Mckenna T. S., Chinsangaram J., Grubman M. J., Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate, Virology (1997) 227:96-102. (Pubitemid 27241058)
32. Mercado R., Vijh S., Allen S. E., Kerksiek K., Pilip I. M., Pamer E. G., Early programming of T cell populations responding to bacterial infection, J. Immunol. (2000) 165:6833-6839. (Pubitemid 32001151)
33. Mohapatra J. K., Sanyal A., Hemadri D., Tosh C., Kumar R. M., Bandyopadhyay S. K., Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome, Biochem. Biophys. Res. Commun. (2005) 329:1133-1138. (Pubitemid 40341392)
34. O'Reilly E. K., Kao C. C., Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure, Virology (1998) 252:287-303. (Pubitemid 29013410)
35. Paglia P., Medina E., Arioli I., Guzman C. A., Colombo M. P., Gene transfer in dendritic cells induced by oral DNA vaccination with Salmonella typhimurium results in protective immunity against a murine fibrosarcoma, Blood (1998) 92:3172-3176. (Pubitemid 28492324)
36. Pereira H. G., Foot-and-mouth disease, in: Gibbs E. P. J. (Ed.), Virus diseases of food animals, Academic Press, Inc., San Diego, California, 1981, pp. 333-363.
37. Prato Murphy M. L., Meyer R. F., Mebus C., Schudel A. A., Rodriguez M., Analysis of sites of FMDV persistence in carrier cattle via the polymerase chain reaction, Arch. Virol. (1994) 136:299-307. (Pubitemid 2101755)
38. Reed L. J., Muench H. A., A simple method of estimating fifty percent end points, Am. J. Hyg. (1938) 27:493-497.
39. Rigden R. C., Carrasco C. P., Barnett P. V., Summerfield A., McCullough K. C., Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs, Vaccine (2003) 21:1466-1477. (Pubitemid 36263188)
40. Shen C., Buck A. K., Liu X., Winkler M., Reske S. N., Gene silencing by adenovirus-delivered siRNA, FEBS Lett. (2003) 539:111-114. (Pubitemid 36351297)
41. Shiau A. L., Chen Y. L., Liao C. Y., Huang Y. S., Wu C. L., Prothymosin enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis, Vaccine (2001) 19:3947-3956.
42. Song E., Lee S. K., Dykxhoorn D. M., Novina C., Zhang D., Crawford K., et al., Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages, J. Virol. (2003) 77:7174-7181. (Pubitemid 36734486)
43. Srinivasan A., Foley J., Ravindran R., McSorley S. J., Low-dose Salmonella infection evades activation of flagellin-specific CD4 T cells, J. Immunol. (2004) 173:4091-4099. (Pubitemid 39280774)
44. Steitz T. A., A mechanism for all polymerases, Nature (1998) 391:231-232.
45. Sun T., Lu P., Wang X., Localization of infection-related epitopes on the nonstructural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes, J. Virol. Methods (2004) 119:79-86. (Pubitemid 38670398)
46. Ter Brake O., Konstantinova P., Ceylan M., Berkhout B., Silencing of HIV-1 with RNA interference: a multiple shRNA approach, Mol. Ther. (2006) 14:883-892. (Pubitemid 44743127)
47. Woo P., Wong L., Zheng B., Yuen K., Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium, Vaccine (2001) 19:2945-2954. (Pubitemid 32244288)
48. Zhao L. J., Jian H., Zhu H., Specific gene inhibition by adenovirus-mediated expression of small interfering RNA, Gene (2003) 316:137-141. (Pubitemid 37249361)
49. Zimmermann T. S., Lee A. C. H., Akinc A., Bramlage B., Bumcrot D., Fedoruk M. N., et al., RNAi-mediated gene silencing in non-human primates, Nature (2006) 441:111-114.